Literature DB >> 20704571

Survivin and IAP proteins in cell-death mechanisms.

Dario C Altieri1.   

Abstract

From the realization that cell number homoeostasis is fundamental to the biology of all metazoans, and that deregulation of this process leads to human diseases, enormous interest has been devoted over the last two decades to map the requirements of cell death and cell survival. This effort has led to tangible progress, and we can now chart with reasonable accuracy complex signalling circuitries controlling cell-fate decisions. Some of this knowledge has translated into novel therapeutics, and the outcome of these strategies, especially in cancer, is eagerly awaited. However, the function of cell-death modifiers have considerably broadened over the last few years, and these molecules are increasingly recognized as arbiters of cellular homoeostasis, from cell division, to intracellular signalling to cellular adaptation. This panoply of functions is best exemplified by members of the IAP (inhibitor of apoptosis) gene family, molecules originally narrowly defined as endogenous caspase inhibitors, but now firmly positioned at the crossroads of multiple normal and transformed cellular responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20704571      PMCID: PMC3198835          DOI: 10.1042/BJ20100814

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  105 in total

1.  Final stages of cytokinesis and midbody ring formation are controlled by BRUCE.

Authors:  Christian Pohl; Stefan Jentsch
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

Review 2.  IAPs: what's in a name?

Authors:  Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

3.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

Authors:  Mathieu J M Bertrand; Snezana Milutinovic; Kathleen M Dickson; Wai Chi Ho; Alain Boudreault; Jon Durkin; John W Gillard; James B Jaquith; Stephen J Morris; Philip A Barker
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

Review 4.  Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation.

Authors:  Mary X D O'Riordan; Laura D Bauler; Fiona L Scott; Colin S Duckett
Journal:  Dev Cell       Date:  2008-10       Impact factor: 12.270

5.  Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation.

Authors:  D J Mahoney; H H Cheung; R Lejmi Mrad; S Plenchette; C Simard; E Enwere; V Arora; T W Mak; E C Lacasse; J Waring; R G Korneluk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

6.  c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.

Authors:  Eugene Varfolomeev; Tatiana Goncharov; Anna V Fedorova; Jasmin N Dynek; Kerry Zobel; Kurt Deshayes; Wayne J Fairbrother; Domagoj Vucic
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

7.  Regulation of apoptosis by XIAP ubiquitin-ligase activity.

Authors:  Andrew J Schile; María García-Fernández; Hermann Steller
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

8.  TNF-alpha induces two distinct caspase-8 activation pathways.

Authors:  Lai Wang; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 9.  Caspases in apoptosis and beyond.

Authors:  J Li; J Yuan
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

Review 10.  IAP-targeted therapies for cancer.

Authors:  E C LaCasse; D J Mahoney; H H Cheung; S Plenchette; S Baird; R G Korneluk
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more
  149 in total

1.  Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis.

Authors:  Prabukumar Anitha; Ramamurthi Vidya Priyadarsini; Krishnamurthy Kavitha; Paranthaman Thiyagarajan; Siddavaram Nagini
Journal:  Eur J Nutr       Date:  2011-12-11       Impact factor: 5.614

2.  Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.

Authors:  Guillaume Jacquemin; Virginie Granci; Anne Sophie Gallouet; Najoua Lalaoui; Aymeric Morlé; Elisabetta Iessi; Alexandre Morizot; Carmen Garrido; Thierry Guillaudeux; Olivier Micheau
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

3.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

Authors:  Jeffrey C Horowitz; Iyabode O Ajayi; Priya Kulasekaran; David S Rogers; Joshua B White; Sarah K Townsend; Eric S White; Richard S Nho; Peter D R Higgins; Steven K Huang; Thomas H Sisson
Journal:  Int J Biochem Cell Biol       Date:  2011-10-25       Impact factor: 5.085

4.  The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer.

Authors:  Hao Deng; Hongyan Zhen; Zhengqi Fu; Xuan Huang; Hongyan Zhou; Lijiang Liu
Journal:  Oncol Lett       Date:  2011-09-16       Impact factor: 2.967

5.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

6.  Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.

Authors:  Sanjib Chowdhury; Gillian M Howell; Carol A Teggart; Aparajita Chowdhury; Jonathan J Person; Dawn M Bowers; Michael G Brattain
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

7.  Survivin and p53 expression in primary and recurrent pterygium in Chinese patients.

Authors:  Li-Wei Zhang; Bai-Hua Chen; Xing-Hua Xi; Qian-Qian Han; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

8.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

Review 9.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

10.  Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.

Authors:  Xi-Ping Tang; Guo-Du Tang; Chun-Yun Fang; Zhi-Hai Liang; Lu-Yi Zhang
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.